ExodusPoint Capital Management’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,568
Closed -$95K 2429
2022
Q2
$95K Buy
18,568
+1,731
+10% +$8.88K ﹤0.01% 1746
2022
Q1
$111K Sell
16,837
-32,241
-66% -$353K ﹤0.01% 1994
2021
Q4
$898K Sell
49,078
-4,616
-9% -$153K 0.01% 1133
2021
Q3
$2.23M Buy
53,694
+33,210
+162% +$1.53M 0.03% 685
2021
Q2
$1.24M Sell
20,484
-1,235
-6% -$76.2K 0.01% 899
2021
Q1
$1.4M Buy
21,719
+12,737
+142% +$875K 0.02% 732
2020
Q4
$377K Sell
8,982
-6,859
-43% -$249K ﹤0.01% 1417
2020
Q3
$567K Sell
15,841
-32,780
-67% -$1.26M 0.01% 950
2020
Q2
$1.76M Buy
+48,621
New +$1.97M 0.05% 477

Other funds holding GTH

ExodusPoint Capital Management's GTH Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of Genetron Holdings Limited ADS (GTH) in Q3 2022, closing a stake of 18,568 shares — an estimated $95K sold.

ExodusPoint Capital Management first reported a position in GTH in Q2 2020 and held it in 9 quarters. The position peaked at $2.23M in Q3 2021. 25 funds tracked by Wall St. Rank hold GTH as of Q3 2022.

  • ExodusPoint Capital Management reported no remaining Genetron Holdings Limited ADS position as of Q3 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 18,568 Genetron Holdings Limited ADS shares in Q3 2022, an estimated $95K.
  • ExodusPoint Capital Management first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 9 quarters.
  • ExodusPoint Capital Management's Genetron Holdings Limited ADS position peaked at $2.23M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.